News and research.
US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African Operations
AUSTIN, TX, November 10, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options in clinical trials, recently...
Secondary conditions and race/ethnicity affect type 2 diabetes patients’ interest in clinical trial participation.
SubjectWell recently fielded a survey engaging over 300 type 2 diabetes patients. The findings showed that diabetes patients demonstrated high overall interest in clinical trial participation,...
Clinical trial recruitment platform SubjectWell scores $35M
MobiHealthNews
SubjectWell collects $35M
PitchBook
SubjectWell Raises $35 Million to Expand Patient Access to New Treatment Options
AUSTIN, TX, October 18, 2022 – SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, today announced a $35...
Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest.
Minority populations are significantly underrepresented in clinical research. When comparing the FDA’s recent Drug Trial Snapshots data with US Census data, women, white patients, and older...
Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S.
ACRP Clinical Researcher
Bilingual staff boost Spanish speaker interest in trials: study
Outsourcing-Pharma.com
Spanish-speaking patients show strong interest in clinical trial participation in the US.
For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result...
SubjectWell expands trial recruitment marketplace to oncology indications
Outsourcing-Pharma.com
Non-small cell lung cancer patients show strong interest in clinical trial participation across disease progression.
In February 2022, SubjectWell announced the expansion of its proven marketplace to include oncology clinical trials, beginning with non-small cell lung cancer (NSCLC). Lung cancer is...
SubjectWell Announces Marketplace Expansion into Oncology Clinical Trials
AUSTIN, TX, March 16, 2022 – SubjectWell, the risk-free clinical trials marketplace for patient recruitment, announced today it has expanded its services to include oncology clinical...
SubjectWell expands its proven marketplace to include non-small cell lung cancer trials
SubjectWell has been providing risk-free patient recruitment for 10 years, building awareness of the benefits of clinical research and offering choice to patients with chronic ambulatory...
Younger Parkinson’s Patients Show Strong Interest in Trial Participation
ACRP - Clinical Researcher
Younger Parkinson’s patients show strong interest in clinical trial participation and high comfort with digital research technology.
Parkinson’s disease (PD), a lifelong and progressive neurological condition, affects about one million people in the United States alone. Primary PD symptoms involve motor impairments, like...
These 9 Austin Tech Companies Are Hiring Right Now
BuiltInAustin.com
Rise of DCTs calls for elevated patient recruitment strategy
Outsourcing-Pharma.com
How decentralized clinical trials disrupt traditional patient recruitment
PharmaceuticalOutsourcing.com
Survey of asthma patients found subgroup with limited acceptance of diagnosis.
In the US today, approximately 20 million adults have asthma. With no cure for asthma, around 8% of Americans use medication to prevent asthma attacks and...
Higher frequency of HCP visits in the US correlates to greater likelihood of clinical trial participation.
In our most recent international survey of patients in Canada, South Africa and the US measuring the impact of healthcare usage, we found the country with...
International survey shows country with lowest healthcare usage and trust correlates to highest likelihood of clinical trial participation.
Quality care in any healthcare system relies heavily on patients developing and maintaining trust in their healthcare professionals (HCPs). As we’ve witnessed throughout the COVID-19 pandemic,...
Reify, SubjectWell partner to elevate trial recruitment
Outsourcing-Pharma.com
The Rise of Decentralized Clinical Trials Is Disrupting Traditional Patient Recruitment
Buzz about decentralized clinical trials (DCTs) and hybrid designs has been around for years; however, it took the in-person restrictions brought about by COVID-19 to accelerate...
Surprisingly, patients are more willing to participate in a COVID-19 vaccine trial as coronavirus vaccines become more widely available.
Marking more than a year since the pandemic began, the world has witnessed how essential clinical research is to creating safe, life-changing treatments. And, more specifically,...
Reify Health and SubjectWell Launch Partnership to Boost Patient Recruitment for Clinical Trials
AUSTIN, TX and BOSTON, MA, March 31, 2021 – Reify Health, provider of leading cloud-based solutions that empower the clinical trial ecosystem, and SubjectWell, the risk-free clinical...
Survey reveals thoughts on trial participation from patients at-risk for liver disease
Outsourcing-Pharma.com
As liver disease cases rise in the US, data shows that patients both at-risk and with a diagnosis of liver disease are willing to participate in clinical research.
Known as the silent liver disease, nonalcoholic fatty liver disease (NAFLD) affects between 30% and 40% of all adults in the US. Fatty liver disease (FLD)...
Concerns around clinical trial participation continue to differ by race.
Since the start of the pandemic, SubjectWell has kept a close eye on patient attitudes and feelings toward clinical trials. After all, right now is arguably...
SubjectWell and Reify Health Surveyed Clinical Trial Sites, Examined Patient Concerns and Site Safety Protocols in the Face of COVID-19
AUSTIN, TX and BOSTON, MA, October 7, 2020 – SubjectWell, the risk-free clinical trials marketplace, and Reify Health, provider of leading cloud-based solutions that empower the clinical...
SubjectWell eyes diversity in COVID-19 vaccine trials
Outsourcing-Pharma.com
SubjectWell Recruits Patients for COVID-19 Vaccine Clinical Trials, Works to Address Lack of Racial Diversity in Patient Recruitment To Date
Austin, TX, August 25, 2020 – SubjectWell, the largest risk-free clinical trials marketplace, announced today it is working with leading pharmaceutical companies to recruit patients for Phase...
Race and gender play a role in patient sentiment toward clinical research during the COVID-19 pandemic.
At SubjectWell, we continue to conduct surveys with patients to understand how their attitudes and feelings toward clinical trials have been altered in the wake of...
Registry connects COVID-19 trials with motivated patients
Outsourcing-Pharma.com
Patient attitudes toward clinical research continue to evolve during the COVID-19 pandemic.
At SubjectWell, we have been conducting an ongoing survey since the beginning of the pandemic to understand how patient attitudes toward clinical research participation have been...
SubjectWell Offers Registry of more than 10,000 Patients Willing to Participate in COVID-19 Research
Pharmaceutical Outsourcing
SubjectWell Offers Registry of Patients Willing to Participate in COVID-19 Research
Applied Clinical Trials
SubjectWell Offers Researchers Registry of 10K+ Patients Willing to Participate in COVID-19 Research
Austin, TX, May 13, 2020 – As the pharmaceutical industry mobilizes at unprecedented speed to develop a COVID-19 vaccine, SubjectWell, the world’s largest marketplace for clinical...
A growing number of patients are considering clinical trials as the coronavirus pandemic continues.
In our ongoing effort to both understand patients’ evolving attitudes toward clinical trial participation in the face of COVID-19 and support our industry’s continued commitment to...
Despite COVID-19, Patients Are Interested In New Trials
Clinical Leader
Data shows a majority of patients remain interested in clinical trials during the coronavirus pandemic.
The coronavirus pandemic has impacted clinical trial operations with unprecedented speed and severity. In order to gauge how the industry and the public are responding, our...